Julie Papanek

Julie Papanek is a healthcare venture capitalist at Canaan Partners, a multi-sector early stage VC firm with over $3 billion under management. She primarily leads investments in pharmaceutical and digital health start-ups.

Before arriving at Canaan, Julie worked at Genentech in a variety of positions spanning marketing, development and business development. Julie is passionate about mentoring entrepreneurs, improving clinical outcomes and expanding consumer access to healthcare. Beyond her work with portfolio companies, Julie is an advisor to the BIO Annual International Conference and is a National Cancer Institute grant reviewer.

She holds an MBA from Stanford, a Master’s Degree from the Biotechnology Institute at Cambridge University and a BSc in Molecular Biophysics & Biochemistry from Yale University.